Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


25.02.2019

1 Ann Neurol
1 Biochemistry
1 Exp Neurol
1 J Clin Pharmacol
1 J Neurosci
5 Mov Disord
2 Nat Rev Neurol
1 Neuropsychology
3 Neurosci Lett
1 Neuroscience


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. GOLDMAN SM, Marek K, Ottman R, Meng C, et al
    Concordance for Parkinson's Disease in Twins: a 20-Year Update.
    Ann Neurol. 2019 Feb 20. doi: 10.1002/ana.25441.
    PubMed     Text format     Abstract available


    Biochemistry

  2. PAN B, Petersson EJ
    A PARP-1 Feed-Forward Mechanism To Accelerate alpha-Synuclein Toxicity in Parkinson's Disease.
    Biochemistry. 2019;58:859-860.
    PubMed     Text format    


    Exp Neurol

  3. DOMENICI RA, Campos ACP, Maciel ST, Berzuino MB, et al
    Parkinson's disease and pain: Modulation of nociceptive circuitry in a rat model of nigrostriatal lesion.
    Exp Neurol. 2019;315:72-81.
    PubMed     Text format     Abstract available


    J Clin Pharmacol

  4. DAMASCENO DOS SANTOS EU, Duarte EBC, Miranda LMR, Asano AGC, et al
    Pharmacogenetic Profile and the Occurrence of Visual Hallucinations in Patients With Sporadic Parkinson's Disease.
    J Clin Pharmacol. 2019 Feb 22. doi: 10.1002/jcph.1394.
    PubMed     Text format     Abstract available


    J Neurosci

  5. VIANA MAGNO LA, Tenza-Ferrer H, Collodetti M, Felipe Guimaraes Aguiar M, et al
    Optogenetic stimulation of the M2 cortex reverts motor dysfunction in a mouse model of Parkinson's Disease.
    J Neurosci. 2019 Feb 19. pii: JNEUROSCI.2277-18.2019.
    PubMed     Text format     Abstract available


    Mov Disord

  6. HENDERSHOTT TR, Zhu D, Llanes S, Zabetian CP, et al
    Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale-2 in Parkinson's disease.
    Mov Disord. 2019;34:285-291.
    PubMed     Text format     Abstract available

  7. ALCALAY RN, Mallett V, Vanderperre B, Tavassoly O, et al
    SMPD1 mutations, activity, and alpha-synuclein accumulation in Parkinson's disease.
    Mov Disord. 2019 Feb 20. doi: 10.1002/mds.27642.
    PubMed     Text format     Abstract available

  8. LIN CH, Chen PL, Tai CH, Lin HI, et al
    A clinical and genetic study of early-onset and familial parkinsonism in taiwan: An integrated approach combining gene dosage analysis and next-generation sequencing.
    Mov Disord. 2019 Feb 20. doi: 10.1002/mds.27633.
    PubMed     Text format     Abstract available

  9. IKEDA A, Shimada H, Nishioka K, Takanashi M, et al
    Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features.
    Mov Disord. 2019 Feb 17. doi: 10.1002/mds.27623.
    PubMed     Text format     Abstract available

  10. FANCIULLI A, Goebel G, Lazzeri G, Scherfler C, et al
    Early distinction of Parkinson-variant multiple system atrophy from Parkinson's disease.
    Mov Disord. 2019 Feb 20. doi: 10.1002/mds.27635.
    PubMed     Text format    


    Nat Rev Neurol

  11. ESPAY AJ, Marras C
    Clinical Parkinson disease subtyping does not predict pathology.
    Nat Rev Neurol. 2019 Feb 20. pii: 10.1038/s41582-019-0153.
    PubMed     Text format    

  12. LIMOUSIN P, Foltynie T
    Long-term outcomes of deep brain stimulation in Parkinson disease.
    Nat Rev Neurol. 2019 Feb 18. pii: 10.1038/s41582-019-0145.
    PubMed     Text format     Abstract available


    Neuropsychology

  13. JOHARI K, Walenski M, Reifegerste J, Ashrafi F, et al
    Sex, dopamine, and hypokinesia: A study of inflectional morphology in Parkinson's disease.
    Neuropsychology. 2019 Feb 18. pii: 2019-08240-001. doi: 10.1037/neu0000533.
    PubMed     Text format     Abstract available


    Neurosci Lett

  14. KUMARI N, Agrawal S, Kumari R, Sharma D, et al
    Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo [4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson's disease.
    Neurosci Lett. 2018;675:74-82.
    PubMed     Text format     Abstract available

  15. PUPYSHEV AB, Korolenko TA, Akopyan AA, Amstislavskaya TG, et al
    Suppression of autophagy in the brain of transgenic mice with overexpression of capital A, Cyrillic53capital TE, Cyrillic-mutant alpha-synuclein as an early event at synucleinopathy progression.
    Neurosci Lett. 2018;672:140-144.
    PubMed     Text format     Abstract available

  16. ZHANG S, Chen S, Liu A, Wan J, et al
    Inhibition of BDNF production by MPP(+) through up-regulation of miR-210-3p contributes to dopaminergic neuron damage in MPTP model.
    Neurosci Lett. 2018;675:133-139.
    PubMed     Text format     Abstract available


    Neuroscience

  17. HAIYANZHANG, Yang J, Xiang T, Sun S, et al
    State-Dependent Spike and Local Field Synchronization between the Thalamic Parafascicular Nucleus and the Dorsal Striatum in a Rat Model of Parkinson's Disease.
    Neuroscience. 2019 Feb 18. pii: S0306-4522(19)30082.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: